Verification of the chemical composition and specifications of haemodialysis membranes by NMR and GPC-FTIR-coupled spectroscopy

Biomaterials

Volumn 23, Issue 15, 2002, Pages 3131-3140

  Gores, F ^a   Montag, P ^a   Schall, C ^b   Vienken, J ^c   Bowry, S K ^c  

^a Polymer Standards Service GmbH   (Germany)

^b FRESENIUS MEDICAL CARE   (Germany)

^c NONE   (Germany)

Author keywords

Dialysis membrane composition; Nomenclature; Specification

Indexed keywords

DIALYSIS MEMBRANES; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GEL PERMEATION CHROMATOGRAPHY; GLASS TRANSITION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT TREATMENT; POLYMERS;

HAEMODIALYSIS;

BIOMATERIALS;

2 PROPANOL; HEXAFLUORO 2 PROPANOL; N,N DIMETHYLACETAMIDE; POLYAMIDE; POLYETHERSULFONE; SOLVENT; UNCLASSIFIED DRUG; BIOMATERIAL; NYLON;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; DIALYSIS MEMBRANE; GEL PERMEATION CHROMATOGRAPHY; GLASS TRANSITION TEMPERATURE; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ARTIFICIAL KIDNEY; ARTIFICIAL MEMBRANE; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; GEL CHROMATOGRAPHY; HUMAN; INSTRUMENTATION; MATERIALS TESTING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RENAL REPLACEMENT THERAPY;

BIOCOMPATIBLE MATERIALS; CALORIMETRY, DIFFERENTIAL SCANNING; CHROMATOGRAPHY, GEL; HUMAN; KIDNEY, ARTIFICIAL; MAGNETIC RESONANCE SPECTROSCOPY; MATERIALS TESTING; MEMBRANES, ARTIFICIAL; NYLONS; RENAL DIALYSIS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; HUMANS;

EID: 0035999760     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(02)00057-1     Document Type: Article

References (40)

1. Artificial dialysis membranes: From concept to large scale production
2. Focussing on membranes
3. Hemodialysis leucopenia: Pulmonary vascular leucostasis resulting from complement activation of dialyser cellophane membranes
4. Biocompatibility issues in hemodialysis
5. Biocompatibility in haemodialysis: Fact and fiction
6. Clinical implications of hemodialysis membrane biocompatibility
7. Considerations on developmental aspects of biocompatible dialysis membranes
8. Biocompatibility of membranes used in the treatment of renal failure
9. Polymer hollow fiber membranes for removal of toxic substances from blood
10. Biocompatibility differences with respect to the dialyser sterilization method
11. Basic features of the polyamide membranes
12. Quality of water and dialysate in haemodialysis
13. New membranes: The promise of ingenuity
14. Miscibility behavior of polyamide 11/sulfonated polysulfone blends using thermal and spectroscopic techniques
15. Quantitative analysis of copolymers by GPC/FT-IR
16. Process analytical chemistry
17. GPC/FTIR characterisation of polymer systems utilising a solvent evaporative interface
18. Synthesis properties of reactively compatibilized polyester and polyamide blends
19. Morphological characteriszation of blends of metal-sulfonated polystyrene and a methylated polyamide by solid-state NMR
20. Compatibilization of polymer blends by complexation. 1. Spectroscopic characteriszation of interactions in ionomer/polyamide blends
21. Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis
22. Effect of the dialysis membrane on mortality of chronic hemodialysis patients
23. Effect of the dialysis membrane in the treatment of patients with acute renal failure
24. Trends in treatment and survival for hemodialysis patients in the United States
25. Influence of membranes on morbidity
26. Role of contact system activation in hemodialyser-induced thrombohenicity
27. Removal of serum beta-2- microglobulin using high-performance membranes and analysis of changes in serum BMG levels after dialysis
28. Permeability andsorption capacity of membranes to lipid A
29. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters
30. Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of haemodialysis patients
31. Morbidity and mortalità in ESRD patients on convective or on diffusive extracorporael treatment
32. Long-term comparative evaluation of synthetic and cellulosic membranes in dialysis
33. End-stage renal disease in the USA: Data from the United States renal data system
34. Relationship of dialysis membrane and cause-specific mortality
35. Progress in dialysis technology: Membrane selection and patient outcome
36. A microdomain-structured synthetic high-flux hollow fibre membrane for renal replacement therapy
37. A comparison of on-line hemodiafiltration and high-flux hemodialysis: A prospective clinical study